Critical Path Institute (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed as ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on VYGR stock, giving a Buy rating today. Patrick ...

Annovis Bio (ANVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju ...

MTC has, however, already been studied as an Alzheimer's therapy, so TauRx selected a low dose (4 mg taken twice a week) that it thought would discolour the urine, but not have any therapeutic effect.

At this time, all participants are in a listen-only mode. Later, there will be a question-and-answer session, and instructions will be given at that time. Please note that today's call is being ...

Beyond Parkinson's, C-Path's drug development solutions have contributed to the first-ever approvals of disease-modifying ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Bobby Allison, founder of racing's "Alabama Gang" and a NASCAR Hall of Famer, died Saturday. He was 86. NASCAR released a ...

Some of the most common types of dementia are Alzheimer’s disease, vascular dementia, Lewy body disease, and fronto-temporal dementia. However, Alzheimer’s disease is by far the most common ...

BUENOS AIRES — Three people were charged in connection with the death of Liam Payne, a former member of musical group One ...

When is the Path of Exile 2 release date? Path of Exile 2 has now evolved from its initial role as effectively a large expansion to become its own full game, with completely new mechanics ...